ADPT
ADPT
US00650F1093
Adaptive Biotechnologies Corpor
Loading chart...

Company Profile

-

Related stocks

BLLN
BLLN • United States
BillionToOne, Inc.
98.09 USD
4.63B USD
VCYT
VCYT • United States
Veracyte, Inc.
45.23 USD
3.64B USD 1Y +24.2%
SHC
SHC • United States
Sotera Health Company
18.06 USD
5.15B USD 1Y +11.4%
CDNA
CDNA • United States
CareDx, Inc.
63.67 USD
3.29B USD 1Y +320.6%
WGS
WGS • United States
GeneDx Holdings Corp.
67.33 USD
2.01B USD 1Y -44.8%
NEO
NEO • United States
NeoGenomics, Inc.
16.35 USD
2.13B USD 1Y +74.7%
PSNL
PSNL • United States
Personalis, Inc.
16 USD
1.71B USD 1Y +85%
RDNT
RDNT • United States
RadNet, Inc.
70.91 USD
5.58B USD 1Y -10.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
78.7% p.a.
Max Drawdown (5Y)
-93.7%
Sharpe Ratio (5Y)
-0.09
Beta Factor
2.10
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 272%.
High market risk: Beta of 2.10 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (78.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -93.7% in the extended horizon.
ende